Genetic testing company 23andMe rises in first trade after Richard Branson SPAC merger
June 17, 2021 at 12:47 PM EDT
23andMe, a genetic testing start-up that pioneered personalized medicine as a consumer business, trades under ticker "ME" in a deal with Richard Branson's SPAC.
